thermal_mass
Fourth batch tested independently. Two surprises so far.
13kreputation
35answers
8accepted
30questions
0·1·7badges g·s·b
60tags
68Is a 31G needle the right choice for drawing ecnoglutide at 20 mg/mL?answered 10 Dec 2024 · needle-gauge, injection-technique, dead-space63What accept/reject threshold would you set for dulaglutide before seeing the result?answered 7 Nov 2024 · batch-testing, harm-reduction, coa50Does liraglutide adsorb measurably to the vial wall at 2.5 mg/mL?answered 21 Nov 2025 · peptide-stability, content-assay, storage41Is a 29G needle the right choice for drawing dulaglutide at 2 mg/mL?accepted · answered 17 Jul 2024 · needle-gauge, injection-technique, dead-space38Is an 18G drawing needle the right choice for drawing orforglipron at 2 mg/mL?accepted · answered 28 Jun 2026 · needle-gauge, injection-technique, dead-space36Is a 31G needle the right choice for drawing survodutide at 5 mg/mL?accepted · answered 8 Apr 2026 · needle-gauge, injection-technique, dead-space31How many units on a U-100 insulin syringe is a 2.5 mg dose at 20 mg/mL?answered 22 May 2025 · dosing-math, insulin-syringe, reconstitution30What is the dead-space loss per draw with a 30G needle at 5 mg/mL?answered 6 Nov 2024 · dead-space, insulin-syringe, dosing-math29Does DEXA or BIA give me a usable lean-mass trend?answered 2 Apr 2024 · dexa, lean-mass, muscle-loss28Is a 31G needle the right choice for drawing survodutide at 8 mg/mL?accepted · answered 23 Mar 2025 · needle-gauge, injection-technique, dead-space28What interval makes sense for repeating albumin-to-creatinine ratio on retatrutide?answered 7 Aug 2024 · bloodwork, harm-reduction, a1c27Is a 29G needle the right choice for drawing ecnoglutide at 20 mg/mL?answered 7 Oct 2025 · needle-gauge, injection-technique, dead-space23Do air bubbles in an insulin syringe matter at these volumes?accepted · answered 13 Aug 2024 · insulin-syringe, injection-technique, dosing-math23Is a 25G drawing needle the right choice for drawing tirzepatide at 2.5 mg/mL?answered 17 Oct 2025 · needle-gauge, injection-technique, dead-space23Is an 18G drawing needle the right choice for drawing orforglipron at 20 mg/mL?answered 29 Oct 2024 · needle-gauge, injection-technique, dead-space22What did the placebo arm of PIONEER-1 report for injection-site erythema?answered 26 Dec 2024 · clinical-trials, injection-site-reaction20Is a 30G needle the right choice for drawing mazdutide at 10 mg/mL?answered 28 Dec 2025 · needle-gauge, injection-technique, dead-space18Does racemisation of retatrutide at 2–8 °C show up as a loss of content or of purity?answered 20 Jul 2026 · peptide-stability, content-assay, purity18Is a 25G drawing needle the right choice for drawing liraglutide at 10 mg/mL?answered 19 Mar 2025 · needle-gauge, injection-technique, dead-space17Is 4 mg in 0.5 mL of phosphate-buffered diluent a sensible presentation for orforglipron?answered 26 Jul 2026 · diluent-volume, reconstitution, dosing-math16Would you accept 98.4% on dulaglutide from QYB without a content assay?answered 16 Sept 2025 · purity, content-assay, vendor-vetting14Is a 25G drawing needle the right choice for drawing cagrilintide at 10 mg/mL?answered 28 Oct 2025 · needle-gauge, injection-technique, dead-space13Is a 25G drawing needle the right choice for drawing cagrilintide at 2.5 mg/mL?answered 25 Apr 2024 · needle-gauge, injection-technique, dead-space13Is a 29G needle the right choice for drawing survodutide at 5 mg/mL?answered 6 Jul 2026 · needle-gauge, injection-technique, dead-space12What is the dead-space loss per draw with a 27G needle at 3.33 mg/mL?answered 19 Mar 2025 · dead-space, insulin-syringe, dosing-math11Is a 29G needle the right choice for drawing semaglutide at 3.33 mg/mL?answered 21 Feb 2025 · needle-gauge, injection-technique, dead-space10How long does oral semaglutide stay within specification at 37 °C once reconstituted?answered 21 Jul 2026 · peptide-stability, storage, shelf-life8Is nausea on a GLP-1 receptor agonist dose-dependent or dose-rate dependent?answered 15 Jun 2025 · nausea, titration7Is a 30G needle the right choice for drawing tirzepatide at 6.67 mg/mL?answered 12 Feb 2026 · needle-gauge, injection-technique, dead-space6How does site choice change absorption kinetics in practice?answered 11 May 2025 · subcutaneous, injection-technique, glp1-mechanism6What should be in place before a first oral semaglutide vial arrives from Chengdu?answered 20 Sept 2024 · harm-reduction, research-use-only, sterility5Is a 30G needle the right choice for drawing tirzepatide at 4 mg/mL?answered 3 Jan 2026 · needle-gauge, injection-technique, dead-space-1Is a 25G drawing needle the right choice for drawing tirzepatide at 2.5 mg/mL?accepted · answered 8 Nov 2025 · needle-gauge, injection-technique, dead-space-2What is the dead-space loss per draw with a 27G needle at 5 mg/mL?accepted · answered 25 Apr 2024 · dead-space, insulin-syringe, dosing-math-2What is the dead-space loss per draw with a 30G needle at 3.33 mg/mL?accepted · answered 11 Nov 2024 · dead-space, insulin-syringe, dosing-math